Leveraging Technology and Expertise to Protect Clinical Trial Supply
In this issue of the IBI Journal, Sarah McAliskey shares invaluable insights on leveraging technology and expertise to protect clinical trial supply. Her expertise highlights the critical impact of these practices on the pharmaceutical industry. Read more of her feature on pages 56-58.
View Resource